Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019829 (
Hodgkin's disease
)
30,247
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Histone variants play an important role in shaping the mammalian epigenome and their aberrant expression is frequently observed in several types of cancer. However, the mechanisms that mediate their function and the composition of the variant-containing chromatin are still largely unknown. A proteomic interrogation of chromatin containing the different H2A variants macroH2A.1.2,
H2A.Bbd
and H2A revealed a strikingly different protein composition. Gene ontology analysis reveals a strong enrichment of splicing factors as well as components of the mammalian replisome in
H2A.Bbd
-containing chromatin. We find
H2A.Bbd
localizing transiently to sites of DNA synthesis during S-phase and during DNA repair. Cells that express
H2A.Bbd
have a shortened S-phase and are more susceptible to DNA damage, two phenotypes that are also observed in human
Hodgkin's lymphoma
cells that aberrantly express this variant. Based on our experiments we conclude that
H2A.Bbd
is targeted to newly synthesized DNA during replication and DNA repair. The transient incorporation of
H2A.Bbd
may be due to the intrinsic instability of nucleosomes carrying this variant or a faster chromatin loading. This potentially leads to a disturbance of the existing chromatin structure, which may have effects on cell cycle regulation and DNA damage sensitivity.
...
PMID:The histone variant H2A.Bbd is enriched at sites of DNA synthesis. 2475 10